Department of Internal Medicine São Paulo State University(Unesp) Medical School Botucatu 18618687 São Paulo Brazil;
Department of Internal Medicine São Paulo State University(Unesp) Medical School Botucatu 18618687 São Paulo Brazil;
Department of Internal Medicine São Paulo State University(Unesp) Medical School Botucatu 18618687 São Paulo Brazil;
Department of Internal Medicine São Paulo State University(Unesp) Medical School Botucatu 18618687 São Paulo Brazil;
Department of Internal Medicine São Paulo State University(Unesp) Medical School Botucatu 18618687 São Paulo Brazil;
Department of Pathology São Paulo State University(Unesp) Medical School Botucatu 18618687 São Paulo Brazil;
Inflammatory Bowel Disease Program Digestive Disease Center Clínica Universidad de los Andes Santiago 7550000 Chile;
Department of Internal Medicine São Paulo State University(Unesp) Medical School Botucatu 18618687 São Paulo Brazil;
Department of Internal Medicine São Paulo State University(Unesp) Medical School Botucatu 18618687 São Paulo Brazil;
Department of Internal Medicine São Paulo State University(Unesp) Medical School Botucatu 18618687 São Paulo Brazil;
Heart failure; Infliximab; Anti-tumor necrosis factor therapy; Crohn''s disease; Inflammatory bowel disease; Case report;